Polyamine Biosynthesis in relation to K-ras and p-53 mutations in colorectal carcinoma

Scandinavian Journal of Gastroenterology

Volumn 39, Issue 5, 2004, Pages 470-477

  Linsalata, M ^a   Notarnicola, M ^a   Caruso, M G ^a   Di Leo, A ^a   Guerra, V ^a   Russo, F ^a  

^a NATIONAL INSTITUTE FOR DIGESTIVE DISEASES   (Italy)

Author keywords

Colorectal cancer; K ras mutation; ODC activity; p53 mutation; Polyamine levels

Indexed keywords

K RAS PROTEIN; ORNITHINE DECARBOXYLASE; POLYAMINE; PROTEIN P53;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; CODON; COLORECTAL CANCER; CONTROLLED STUDY; ENZYME ACTIVITY; FEMALE; GENE MUTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MUCOSA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RADIOMETRY; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SAMPLING; SINGLE STRAND CONFORMATION POLYMORPHISM; WILD TYPE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLON; COLORECTAL NEOPLASMS; FEMALE; GENES, P53; GENES, RAS; HUMANS; INTESTINAL MUCOSA; MALE; MIDDLE AGED; MUTATION; ORNITHINE DECARBOXYLASE; POLYAMINES;

EID: 2442541067     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/0036552031008755     Document Type: Article

References (44)

1. Pegg AE. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988;48:759-74.
2. Milovic V, Turchanowa L. Polyamines and colon cancer. Biochem Soc Trans 2003;31:381-3.
3. Thomas T, Thomas TJ. Polyamines in cell growth and cell death: molecular mechanisms and therapeutic applications. Cell Mol Life Sci 2001;58:244-58.
4. Kubata S, Kiyosawa H, Nomura Y, Yamada T, Seyama Y. Ornithine decarboxylase overexpression in mouse 10t1/2 fibroblast cellular transformation and invasion. J Natl Cancer Inst 1997;89:567-71.
5. Srivastava S, Verma M, Henson DE. Biomarkers for early detection of colon cancer. Clin Cancer Res 2001;7:1118-26.
6. Harris C, Hollstein M. Clinical implications of the p53 tumor suppressor gene. N Engl J Med 1993;329:1318-27.
7. Patel AR, Wang JY. Polyamines modulate transcription but not posttranscription of c-myc and c-jun in IEC-6 cells. Am J Physiol 1997;273:C1020-9.
8. Tabib A, Bachrach U. Role of polyamines in mediating malignant transformation and oncogene expression. Int J Biochem Cell Biol 1999;31:1289-95.
9. Smith MK, Trempus CS, Gilmour SK. Co-operation between follicular ornithine decarboxylase and v-Ha-ras induces spontaneous papillomas and malignant conversion in transgenic skin. Carcinogenesis 1998;19:1409-15.
10. Shantz LM, Pegg AE. Ornithine decarboxylase induction in transformation by H-Ras and RhoA. Cancer Res 1998;58:2748-53.
11. Lan L, Trempus C, Gilmour SK. Inhibition of ornithine decarboxylase (ODC) decreases tumor vascularization and reverses spontaneous tumors in Odc/Ras transgenic mice. Cancer Res 2000;60:5696-703.
12. Li L, Li J, Rao JN, Li M, Bass BL, Wang J-Y. Inhibition of polyamine synthesis induces p53 gene expression but not apoptosis. Am J Physiol 1999;276:C946-54.
13. Nemoto T, Kamei S, Seyama Y, Kubota S. p53 independent G(1) arrest induced by DL-alpha-difluoromethylornithine. Biochem Biophys Res Commun 2001;280:848-54.
14. Lawson KR, Ignatenko NA, Piazza GA, Cui H, Gerner EW. Influence of K-ras activation on the survival response of caco-2 cells to the chemopreventive agents sulindac and difluoromethylornithine. Cancer Epidemiol Biomarkers Prev 2000;11:1155-62.
15. Singh J, Reddy BS. Molecular markers in chemoprevention of colon cancer. Inhibition of expression of ras-p21 and p53 by sulindac during azoxymethane-induced colon carcinogenesis. Ann NY Acad Sci 1995;768:205-9.
16. Wallace HM, Fraser AV. Polyamine analogues as anticancer drugs. Biochem Soc Trans 2003;31:393-6.
17. Linsalata M, Caruso MG, Leo S, Guerra V, D'Attoma B, Di Leo A. Prognostic value of tissue polyamine levels in human colorectal carcinoma. Anticancer Res 2002;22:2465-70.
18. Notarnicola M, Cavallini A, Cardone R, Pezzolla F, Demma I, Di Leo A. K-ras and p53 mutations in DNA extracted from colonic epithelial cells exfoliated in faeces of patients with colorectal cancer. Digest Liver Dis 2000;32:131-6.
19. Russo F, Linsalata M, Messa C, Cavallini A, Notarnicola M, Guerra V, et al. Polyamines and estrogen receptor concentrations in human colorectal carcinomas. Ital J Gastroenterol 1992;24:8-12.
20. Di Leo A, Linsalata M, Cavallini A, Messa C, Russo F. Sex steroid hormone receptors, epidermal growth factor receptor, and polyamines in human colorectal cancer. Dis Colon Rectum 1992;35:305-9.
21. Linsalata M, Russo F, Cavallini A, Berloco P, Di Leo A. Polyamines, diamine oxidase, and ornithine decarboxylase activity in colorectal cancer and in normal surrounding mucosa. Dis Colon Rectum 1993;36:662-7.
22. Notarnicola M, Linsalata M, Caruso MG, Cavallini A, Di Leo A. Low density lipoprotein receptors and polyamine levels in human colorectal adenocarcinoma. J Gastroenterol 1995;30:705-9.
23. Linsalata M, Cavallini A, Di Leo A. Polyamine oxidase activity and polyamine levels in human colorectal cancer and in normal surrounding mucosa. Anticancer Res 1997;17:3757-60.
24. Porter CW, Herrera-Ornela L, Pera P, Petrelli NF, Mittelman A. Polyamine biosynthetic activity in normal and neoplastic human colorectal tissue. Cancer 1987;60:1275-81.
25. Wallace HM, Caslake R. Polyamine and colon cancer. Eur J Gastroenterol Hepatol 2001;13:1033-9.
26. Linsalata M, Messa C, Russo F, Cavallini A, Di Leo A. Oestrogen receptors and polyamine levels in human gastric carcinoma. Scand J Gastroenterol 1994;29:67-70.
27. Russo F, Linsalata M, Giorgio I, Caruso ML, Armentano R, Di Leo A. Polyamine levels and ODC activity in intestinal-type and diffuse-type gastric carcinoma. Dig Dis Sci 1997;42:576-9.
28. Loser C, Folsch UR, Paprotny C, Creutzfeldt W. Polyamines in human gastric and oesophageal cancer. Scand J Gastroenterol 1989;24:1193-9.
29. Auvinen M, Paasinen A, Andersson LC, Hölttä E. Ornithine decarboxylase activity is critical for cell transformation. Nature 1992;360:355-7.
30. Loser C, Folsch UR, Paprotny C, Creutzfeldt W. Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum, and urine of 50 patients with colorectal cancer. Cancer 1990;65:958-66.
31. Kingsnorth AN, Lumsden AB, Wallace HM. Polyamines in colorectal cancer. Br J Surg 1984;71:791-4.
32. Weiss Bernhardt G, Buschauer A, Thasler WE, Dolgner D, Zirngibl I, Jauch KW. Polyamine levels of human colorectal adenocarcinomas are correlated with tumor stage and grade. Int J Colorectal Dis 2002;17:381-7.
33. Watanabe T, Muto T. Colorectal carcinogenesis based on molecular biology of early colorectal cancer, with special reference to nonpolypoid (superficial) lesion. World J Surg 2000;24:1091-7.
34. Caruso MG, Notarnicola M, Bifulco M, Laezza C, Guerra V, Altomare DF, et al. Increased farnesyltransferase activity in human colorectal cancer: relationship with clinicopathological features and K-ras mutation. Scand J Gastroenterol 2003;38:80-5.
35. Hurta Ra, Lee J, Voskas D. Transformation by H-ras can result in aberrant regulation of ornithine decarboxylase gene expression by transforming growth factor-beta. J Cell Biochem 2001;81:39-55.
36. Sarfati P, Dubé M, Pradayrol L, Morisset J. Increases in Ki-ras and ornithine decarboxylase gene expression in rat pancreas after caerulein-induced pancreatitis. Digestion 1996;57:453-63.
37. Hölttä E, Sistonen L, Alitalo K. The mechanism of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J Biol Chem 1988;263:4500-7.
38. Shayovitis A, Bachrach U. Ornithine decarboxylase: an indicator for growth of NIH 3T3 fibroblast and their c-Ha-ras transformants. Biochim Biophys Acta 1995;1267:107-14.
39. Auvinen M. Cell transformation, invasion, and angiogenesis: a regulatory role for ornithine decarboxylase and polyamines? J Natl Cancer Inst 1997;89:533-7.
40. Li L, Rao JN, Guo X, Liu L, Santora R, Bass BL, et al. Polyamine depletion stabilizes p53 resulting in inhibition of normal intestinal epithelial cell proliferation. Am J Physiol Cell Physiol 2001;281:C941-53.
41. Ray RM, McCormack SA, Johnson LR. Polyamine depletion arrests growth of IEC-6 and Caco-2 cells by different mechanisms. Am J Physiol Gastrointest Liver Physiol 2001;281:G37-43.
42. Elitsur Y, Koh SJ, Moshier JA, Dosescu J, Tureaud J, Majumdar AP. Ornithine decarboxylase and tyrosine kinase activity in juvenile polyps of childhood. Pediatr Res 1995;38:574-8.
43. Notarnicola M, Linsalata M, Caruso MG, Caruso ML, Altomare D, Lorusso D, et al. Genetic and biochemical changes in colorectal carcinoma in relation to morphologic characteristics. Oncol Rep 2003;10:1987-91.
44. Hahm HA, Dunn VR, Kimberly AB, Deveraux WL, Woster PM, Casero RA, et al. Combination of standard cytotoxic agents with polyamine analogues in the treatment of breast cancer cell lines. Clin Cancer Res 2001;7:391-9.